Aseptic Loosening in Total Hip Arthroplasty

Aseptic loosening is the most common indication for revision total hip arthroplasty in the late postoperative period (beyond 5 years). It represents failure of implant fixation due to particle-induced osteolysis rather than infection.

Risk factors for aseptic loosening:

• Young, active patients - higher wear rates
• Obesity - increased joint forces
• Poor implant positioning - edge loading, impingement
• Conventional polyethylene - higher wear
• Thin cement mantles - cement fracture
• Undersized components - inadequate fixation
• Osteolysis-prone patients - genetic factors (cytokine polymorphisms)

The particle disease cascade:

Aseptic loosening is fundamentally a biologic process driven by wear particles, not a purely mechanical phenomenon.

Step 1: Particle Generation

• Polyethylene wear (most common source)
• Metal-on-metal wear (cobalt/chromium particles)
• Ceramic particles (if liner fracture)
• Cement particles (PMMA debris)
• Corrosion products (at modular junctions)

Step 2: Particle Distribution

• Particles migrate along effective joint space
• Enter periprosthetic tissues via joint fluid pumping
• Size matters: 0.1-10 micron particles most biologically active
• Smaller particles more phagocytosable, larger particles accumulate

Step 3: Macrophage Activation

• Macrophages phagocytose wear particles
• Frustrated phagocytosis - cannot digest polyethylene
• Macrophage activation and cytokine release
• Key cytokines: TNF-α, IL-1β, IL-6, RANKL

Step 4: Osteoclast Recruitment

• RANKL binds to RANK on osteoclast precursors
• OPG (osteoprotegerin) normally inhibits RANKL
• Imbalance: RANKL/OPG ratio increased
• Osteoclast activation and bone resorption

Step 5: Osteolysis and Membrane Formation

• Periprosthetic membrane forms (granulation tissue)
• Contains macrophages, giant cells, particles
• Progressive bone resorption creates cystic lesions
• Membrane extends along implant-bone interface

Step 6: Mechanical Loosening

• Loss of bone support
• Micromotion increases
• Further particle generation (vicious cycle)
• Implant migration or subsidence

Genetic factors:

• Polymorphisms in cytokine genes (TNF-α, IL-1)
• Some patients are high responders to particles
• Explains variability in osteolysis rates with similar wear

Differential diagnosis of the painful THA

Aseptic loosening is a diagnosis of exclusion. Systematically consider intrinsic and extrinsic causes before attributing pain to loosening.

Immediate postoperative care:

Revision THA outcomes:

Modern techniques and implants have improved revision THA outcomes substantially.

This section frames aseptic loosening as a global problem, drawing on the major national joint registries as cited evidence rather than the practice of any single country.

Global epidemiology

• THA volume — and therefore the at-risk population for late loosening — is rising worldwide. Registry-based modelling has projected a 208% increase in primary THA for osteoarthritis between 2013 and 2030 in high-income settings. [3] Ageing populations and rising obesity drive similar trends across high-income registries.
• Aseptic loosening / osteolysis is the leading recorded indication for revision THA in registry data; in the National Joint Registry of England and Wales it ranks ahead of dislocation, pain and periprosthetic fracture as a cause of single-stage revision. [1]
• The dominant modifiable driver historically was conventional polyethylene wear; the shift to HXLPE has reduced osteolysis and revision substantially. [2]

Major guidelines and consensus, side by side

Registry evidence (implant survival and revision)

Independent series corroborate registry signals: extensively porous-coated diaphyseal stems show only 3% re-revision for aseptic femoral loosening at 20 years [4], and trabecular-metal/titanium revision cups achieve ~88% survivorship at 10 years in deficient acetabula. [5]

Global practice variation

• Fixation philosophy differs by region: Scandinavian registries retain a strong cemented-stem tradition with excellent long-term results, while practice in North America and Australasia favours uncemented fixation — both achieve low aseptic-loosening rates in modern data.
• Resource setting changes the toolkit: porous-metal augments, cup-cage constructs and custom triflanges [4][5] are standard in high-resource centres, whereas impaction grafting and structural allograft remain important where modular porous metal is less available.
• Diagnostic access to alpha-defensin, leukocyte esterase and extended cultures varies, but the principle — exclude infection before revising a loose THA — is universal. [6]